Transaction · 0001493152-26-045347

Opaleye Management Inc.

Opaleye Management Inc., 10%, reported an open-market or private purchase at Grace Therapeutics, Inc. involving 9771.000000 shares for an estimated $20519.10. Reported holdings after the transaction were 2785000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code P10%
GRCEGrace Therapeutics, Inc.
Trade date
Sep 21, 2026
Filing date
Oct 01, 2026
View on SEC Insider profile
Estimated value$20.5kShares × reported price
Shares traded9.77k$2.10 per share
Holdings after2.78MIndirect · By Opaleye, L.P.
% of reported position traded0.35%This security and ownership context
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 2,775,229 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
2 warnings
amended filingThis transaction comes from an amended Form 4 filing.
delayed filingThe filing was reported 10 calendar days after the transaction date.

GRCE price since this filing

Daily closing prices, with the filing date and available return windows
GRCE · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +7.8%1w ago +12.3%1d ago +3.4%
Returns since7d +0.0%30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001493152-26-045347
Common Stock, par value $0.0001 per share
Transaction date
Sep 21, 2026
Filed Oct 01, 2026, 08:05 PM · 10d delay
Shares
9,771 sh
$2.10 per share
Estimated value
$20.5k
Computed from shares × price
Holdings after
2,785,000 sh
Indirect · By Opaleye, L.P.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Amended Filing Cluster Buy Delayed Filing 10% Owner Buy
Filing-only score

+18 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • ten_percent_owner_buy+4 points

    is_ten_percent_owner = true

    10% beneficial owner open-market purchase.
  • cluster_buy+14 points

    cluster-buy signal matched

    Multiple insiders bought within the configured window.
  • amended_filing-6 points

    is_amendment = true

    Amended filing: the original transaction may have been restated.
  • delayed_filing-6 points

    reporting_delay_days = 10

    Filing delay exceeds the configured threshold.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector No10% YesOther No
Footnotes & amended
  1. F1

    Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by t…

  2. F2

    Opaleye Management, Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an…

Amended filing · 0001493152-26-045347
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

GRCE